arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Amarin Corporation plc

AMRN Health Care Biotechnology: Pharmaceutical Preparations
$11.79
▲ +2.4% Today
as of Oct 23, 16:45 ET
Last 30 days -15.79% Sep 14 → Oct 23
$11.11 $11.88 $12.66 $13.44 $14.21 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$11.62
High
$11.90
Low
$11.40
Volume
$82,768
Avg Vol
$82,258
Mkt Cap
$254M
P/E (TTM)
—
Beta
—
52w High
$20.90
52w Low
$11.25
Div Yield
—
Shares Out
$420M

Recent Press Releases & News last 60 days · 3 items

Oct 21 · 12:00 PR GlobeNewswire
Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026
Sep 9 · 19:54 Zacks
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
Aug 31 · 12:15 PR GlobeNewswire
Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026

AMRN earnings at a glance

Amarin Corporation plc (AMRN) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Analysts expect earnings per share of -$0.28. The options market is pricing a move of about ±14.6% after the report, a range of roughly $10.07 to $13.51 from today's $11.79. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±4.3% on average; after the most recent report on Jul 29, 2026 it moved +0.5%. That means options currently expect more movement than AMRN has typically delivered. AMRN beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 123%. The share price of $11.79 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$11
$21
6% of range
Avg surprise (last 6)
+92.0%
Avg reaction (last 6)
-2.6%
50% positive
Latest IV / EM
123%
EM ±14.6% · $12 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.71$-2.03$-1.35$-0.67$0.01 Actual $-0.04Actual $-0.04Actual $-0.05Actual $-0.02Actual $-0.06Actual $-0.04Est $-1.12Actual $-0.03Est $-0.66Est $-0.07Actual $0.01Est $-1.51Actual $-0.20Est $-2.71Actual $-0.07Est $-0.21 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$-25M$244,012$26M$51M$76M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 29, 2026Jun/2026 $-0.07 $-0.21 +66.7% -600.0% +0.5% earnings
Wed Apr 29, 20268K 2026-04-29 $-0.20 $-2.71 +92.6% — +2.4% earnings
Wed Feb 25, 20268K 2026-02-25 $0.01 $-1.51 +100.7% — -9.5% earnings
Wed Oct 29, 2025Sep/2025 — $-0.07 +100.0% — -11.2% earnings
Wed Jul 30, 2025Jun/2025 $-0.03 $-0.66 +95.5% — +2.2% earnings
Wed May 7, 2025Mar/2025 $-0.04 $-1.12 +96.4% — -0.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.06 — — — — financials
Sun Jun 30, 2024Jun 2024 — — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.02 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.05 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.04 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.04 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER -$0.28—

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$42M$45M—$50M$73M$42M—$42M
Cost of revenue————————
Gross profit$15M$18M—$22M$50M$25M—$16M
Operating income$-12M$-11M—$-11M$-16M$-17M—$-25M
Net income$-8M$-11M—$-8M$-14M$-16M—$-25M
EPS (diluted)$-0.02$-0.03—$-0.02$-0.03$-0.04—$-0.06

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$144M$131M$135M$123M$148M$120M$121M$157M
Inventory$164M$184M$196M$185M$171M$159M$166M$224M
Total current assets$603M$626M$650M$628M$607M$573M$595M$650M
Total assets$624M$646M$671M$660M$670M$656M$685M$751M
Long-term debt————————
Total liabilities$181M$196M$211M$201M$205M$182M$199M$219M
Total equity$444M$449M$459M$459M$465M$474M$486M$531M

Implied volatility — last 90 days

46%135%224%313%402% Jun 07 — IV 86% · EM ±11.8%Jun 08 — IV 77% · EM ±10.2%Jun 09 — IV 94% · EM ±11.8%Jun 10 — IV 100% · EM ±11.9%Jun 11 — IV 73% · EM ±8.1%Jun 12 — IV 85% · EM ±8.7%Jun 15 — IV 140% · EM ±10.1%Jun 16 — IV 134% · EM ±7.9%Jun 17 — IV 402% · EM ±16.8%Jun 19 — IV 92% · EM ±20.4%Jun 22 — IV 65% · EM ±13.6%Jun 23 — IV 75% · EM ±15.3%Jun 24 — IV 72% · EM ±14.3%Jun 25 — IV 87% · EM ±17.1%Jun 26 — IV 100% · EM ±19.2%Jun 29 — IV 85% · EM ±15.1%Jun 30 — IV 120% · EM ±20.7%Jul 01 — IV 76% · EM ±12.8%Jul 02 — IV 94% · EM ±15.3%Jul 03 — IV 98% · EM ±15.3%Jul 06 — IV 85% · EM ±11.8%Jul 07 — IV 137% · EM ±18.1%Jul 08 — IV 72% · EM ±9.1%Jul 09 — IV 70% · EM ±8.3%Jul 13 — IV 204% · EM ±17.0%Jul 14 — IV 197% · EM ±14.3%Jul 15 — IV 208% · EM ±12.3%Jul 20 — IV 93% · EM ±21.9%Jul 21 — IV 85% · EM ±19.7%Jul 22 — IV 81% · EM ±18.4%Jul 23 — IV 80% · EM ±18.0%Jul 24 — IV 83% · EM ±18.4%Jul 27 — IV 74% · EM ±15.4%Jul 28 — IV 74% · EM ±15.1%Jul 29 — IV 55% · EM ±10.9%Jul 30 — IV 66% · EM ±13.0%Jul 31 — IV 65% · EM ±12.4%Aug 03 — IV 77% · EM ±13.6%Aug 04 — IV 77% · EM ±13.2%Aug 05 — IV 105% · EM ±17.5%Aug 06 — IV 88% · EM ±14.2%Aug 07 — IV 74% · EM ±11.5%Aug 10 — IV 79% · EM ±11.0%Aug 11 — IV 81% · EM ±10.7%Aug 13 — IV 75% · EM ±8.8%Aug 14 — IV 68% · EM ±7.5%Aug 17 — IV 154% · EM ±12.8%Aug 18 — IV 191% · EM ±13.8%Aug 19 — IV 218% · EM ±12.9%Aug 20 — IV 145% · EM ±6.0%Aug 24 — IV 62% · EM ±13.0%Aug 25 — IV 54% · EM ±11.1%Aug 26 — IV 76% · EM ±15.3%Aug 27 — IV 68% · EM ±13.3%Aug 28 — IV 47% · EM ±8.9%Aug 31 — IV 63% · EM ±11.2%Sep 01 — IV 55% · EM ±9.4%Sep 02 — IV 59% · EM ±9.9%Sep 03 — IV 56% · EM ±9.1%Sep 04 — IV 56% · EM ±8.8%Sep 07 — IV 64% · EM ±8.8%Sep 08 — IV 81% · EM ±10.7%Sep 09 — IV 79% · EM ±9.9%Sep 10 — IV 133% · EM ±15.7%Sep 11 — IV 75% · EM ±8.3%Sep 14 — IV 83% · EM ±7.0%Sep 15 — IV 69% · EM ±5.0%Sep 16 — IV 86% · EM ±5.1%Sep 17 — IV 147% · EM ±6.1%Sep 21 — IV 74% · EM ±15.4%Sep 22 — IV 60% · EM ±12.2%Sep 23 — IV 54% · EM ±10.8%Sep 24 — IV 60% · EM ±11.7%Sep 25 — IV 57% · EM ±11.0%Sep 28 — IV 59% · EM ±10.4%Sep 29 — IV 61% · EM ±10.5%Sep 30 — IV 68% · EM ±11.3%Oct 01 — IV 60% · EM ±9.6%Oct 02 — IV 104% · EM ±16.2%Oct 06 — IV 93% · EM ±12.2%Oct 07 — IV 96% · EM ±12.1%Oct 08 — IV 123% · EM ±14.6%

Sector peers

IFRX
InflaRx N.V.
$252M $1.56+0.7%
BCYC
Bicycle Therapeutics plc
$261M $3.55-0.6%
QTTB
Q32 Bio Inc.
$246M $8.65-0.2%
AKBA
Akebia Therapeutics, Inc.
$241M $0.57-3.1%
SLGL
Sol-Gel Technologies Ltd.
$238M $69.45+5.7%
SIGA
SIGA Technologies Inc.
$234M $3.120.0%

AMRN earnings FAQ

When is AMRN's next earnings date?

Amarin Corporation plc is expected to report on November 4, 2026.

What is AMRN's expected move for earnings?

Options currently price a move of about ±14.6%, or $1.72 per share either way from $11.79.

How does AMRN stock usually react to earnings?

Across the last 6 reports the average next-day move was ±4.3%, up 3 times and down 3 times.

What EPS are analysts expecting from Amarin Corporation plc?

The consensus estimate is -$0.28 per share.

What is AMRN's implied volatility?

AMRN's at-the-money implied volatility is about 123% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in